1999-08-26T00:00:00
Dr Maggie Harding (letters, 12 August) does a disservice to women with ovarian cancer. She draws attention to the June Effective Health Care Bulletin on the management of gynaecological cancers, which recommends that Paclitaxel and Carboplatin should be the treatment of choice for this disease. Yet she congratulates health authorities ...
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud